Literature DB >> 30109416

A Leishmania-specific gene upregulated at the amastigote stage is crucial for parasite survival.

Kumar Avishek1, Kavita Ahuja2, Dibyabhaba Pradhan1, Sreenivas Gannavaram3, Angamuthu Selvapandiyan2, Hira L Nakhasi3, Poonam Salotra4.   

Abstract

The morphological and biochemical alterations between the two life stages of Leishmania are governed by stage-regulated expression of several genes. Amastigote-specific genes are believed to have a role in the survival and replication of the parasite in the hostile environment of the mammalian host. Previously, we have reported the upregulated expression of A1 gene (LdA1) at the amastigote stage at RNA level. In the present study, we have further characterized LdA1, in order to understand its role in Leishmania. Sequence homology search revealed that LdA1 is unique to the Leishmania genus. Sequence- and structure-level functional annotations predicted the involvement of LdA1 in a range of biological processes critical for survival of the parasites. Western blot confirmed the upregulated expression of LdA1 at the protein level at the amastigote stage. Overexpression of LdA1 in Leishmania did not affect its growth, phenotype, or infectivity. Attempts to generate null mutants of LdA1 by homologous recombination were not successful. Repeated inability to create null mutants of LdA1 was suggestive of gene essentiality. Mutant parasites with a single allele deletion of LdA1 (LdA1+/-) showed reduction in motility, size, and growth rate at both the life stages in vitro, which was restored following gene add-back by episomal expression of LdA1 in mutant parasites. Although LdA1+/- parasites were able to infect macrophages ex vivo, their capacity to survive inside macrophages was reduced significantly (P < 0.01) beyond 72 h of infection. In conclusion, LdA1 is a Leishmania-specific gene having upregulated expression at the amastigote stage and is important for survival of Leishmania parasite.

Entities:  

Keywords:  Amastigote-specific gene; Gene-deleted mutants; Leishmania; Leishmania-specific gene; Live-attenuated parasites; Macrophage infectivity

Mesh:

Substances:

Year:  2018        PMID: 30109416     DOI: 10.1007/s00436-018-6020-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  58 in total

1.  Genomic organisation and expression of a differentially-regulated gene family from Leishmania major.

Authors:  H M Flinn; D F Smith
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  Molecular characterization, expression, and in vivo analysis of LmexCht1: the chitinase of the human pathogen, Leishmania mexicana.

Authors:  Manju B Joshi; Matthew E Rogers; Alison M Shakarian; Mat Yamage; Saeed A Al-Harthi; Paul A Bates; Dennis M Dwyer
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

3.  Deletion of Vitamin C biosynthesis enzyme, Arabino-1, 4-lactone oxidase in Leishmania donovani results in increased pro-inflammatory responses from host immune cells.

Authors:  Reetika Manhas; Sneha Anand; Pankaj Tripathi; Rentala Madhubala
Journal:  Mol Microbiol       Date:  2014-02-21       Impact factor: 3.501

4.  Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.

Authors:  Susan Idicula-Thomas; Petety V Balaji
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

5.  A new developmentally regulated gene family in Leishmania amastigotes encoding a homolog of amastin surface proteins.

Authors:  Y Wu; Y El Fakhry; D Sereno; S Tamar; B Papadopoulou
Journal:  Mol Biochem Parasitol       Date:  2000-10       Impact factor: 1.759

6.  Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.

Authors:  W W Zhang; H Charest; E Ghedin; G Matlashewski
Journal:  Mol Biochem Parasitol       Date:  1996-06       Impact factor: 1.759

7.  The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts.

Authors:  Gerald F Späth; L A Garraway; Salvatore J Turco; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

8.  I-TASSER server: new development for protein structure and function predictions.

Authors:  Jianyi Yang; Yang Zhang
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

Review 9.  Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Authors:  Sreenivas Gannavaram; Ranadhir Dey; Kumar Avishek; Angamuthu Selvapandiyan; Poonam Salotra; Hira L Nakhasi
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

10.  Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.

Authors:  Kumar Avishek; Himanshu Kaushal; Sreenivas Gannavaram; Ranadhir Dey; Angamuthu Selvapandiyan; V Ramesh; Narender Singh Negi; Uma S Dubey; Hira L Nakhasi; Poonam Salotra
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.